Open AccessPB1899: DEVELOPMENT AND VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR THE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE RECEIVING FIRST‐LINE IMATINIB
Author(s) -
Bektaş M.,
Eşkazan A. E.,
Tiryaki T. O.,
Mullai R.,
Elverdi T.,
Salihoğlu A.,
Tiribelli M.,
Ar M. C.,
Öngören S.,
Başlar Z.,
Nalçaci M.,
Soysal T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850448.44505.f6
Subject(s) - medicine , imatinib , myeloid leukemia , proportional hazards model , oncology , cohort , imatinib mesylate , survival analysis , framingham risk score , population , dasatinib , disease , environmental health